IPO Premiums
IPO calendar
IHListed

Influx Healthtech Limited

Bookbuilding IPO · NSE

Price band
₹91 - ₹96
Lot size
1,200 shares
Issue amount
₹58.57 cr
Total subscription
187.32×
Current price₹259.5
Listing price ₹132.5
Watch live price ↗
Opens
18 Jun 2025
Closes
20 Jun 2025
Allotment
23 Jun 2025
Listing
25 Jun 2025

Offer at a glance

Issue overview

Issue size
61,00,800 shares
Face value
₹10 per share
Minimum investment
₹1,09,200
Fresh issue
₹48 cr
Offer for sale
₹10.56 cr
Registrar
Maashitla Securities Private Limited
Listing exchange
NSE
Maximum investment
₹1,15,200
Issue type
Bookbuilding IPO
Shares before issue
1,81,50,000
Shares after issue
2,31,50,400

Lot sizes

CategoryLotsSharesAmount
RETAIL11,200₹1,15,200
HNI22,400₹2,30,400

Share reservation

RETAIL33.26%
HNI14.26%
Anchor28.46%
QIB19%
Market Maker5.02%

Subscription & GMP

Subscription by category

Total subscribed187.32×

Missing multiples are calculated from bids and offered shares when available.

QIB137.87×
NIB481.47×
RETAIL117.7×

GMP history

022.54512 Jun: ₹1213 Jun: ₹2414 Jun: ₹3115 Jun: ₹3516 Jun: ₹3717 Jun: ₹4018 Jun: ₹4519 Jun: ₹3820 Jun: ₹2421 Jun: ₹2224 Jun: ₹2012 Nov: ₹2025 Nov: ₹20
12 Jun₹2025 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
QIB—99
NIB—21,204
RETAIL—1,99,035

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs11.131,534.26
RETAIL19.482,292.88

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
050100150Mar-23 · Revenue: 76.07Mar-23 · Profit after tax: 7.2Mar-23Mar-24 · Revenue: 100.1Mar-24 · Profit after tax: 11.2Mar-24Mar-25 · Revenue: 105Mar-25 · Profit after tax: 13.4Mar-25
RevenueProfit after tax

Key performance indicators

MetricMar-25Mar-24Mar-23
EPS7.366.133.96
ROE36.9848.8561.76
ROCE49.1765.5878.6
RONW36.9836.9861.76
PRE IPO(PE)13.0400
POST IPO(PE)16.6300

Values and labels as reported in the issue data.

Company information

Company profile

Influx Healthtech Limited, established in September 2020, is a healthcare-focused company that provides contract manufacturing services. It operates as a trusted CDMO (Contract Development and Manufacturing Organization), serving clients across various sectors. The company runs three manufacturing units located in Thane, Maharashtra, with facility sizes of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its product range includes tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules, candies, gym and sports supplements, as well as skincare, body care, hair care, beard care products, face masks, and soaps. It also manufactures ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company supports nutraceutical and cosmetic businesses by handling the entire process from product development to manufacturing and regulatory assistance, allowing clients to concentrate on formulation and market launch. As of June 11, 2025, Influx Healthtech Limited employs 163 full-time staff members.

Strengths

  • Wide Product Range – Offers products in pharma, nutraceuticals, and cosmetics
  • Trusted Client Base – Strong relationships with well-known health and wellness brands
  • Strong Quality Control – Follows GMP, FSSAI, and other standards with strict quality checks

Risk factors

  • High Competition – Competes with big CDMO players like Jubilant and Divi’s Labs
  • Raw Material Price Fluctuations – Changing input costs can reduce profit margins
  • Dependence on Key Clients – Losing major customers could impact business stability.

Promoters

Mr. Munir Abdul Ganee Chandniwala

Mrs. Shirin Munir Ahmed Chandniwala

Mr. Abdul Ganee Abdul Rasul Chandniwala

Registrar & documents

Lead manager

Rarever Financial Advisors Private Limited

Registered office

109, Ghanshyam Enclave Premises Co-op Soc Plot No. 856, Laljipada Kandivali West, Mumbai, Maharashtra

+91 7045997809

[email protected]Company website ↗

Frequently Asked Questions

What is Influx Healthtech IPO GMP today?

As of today, Influx Healthtech IPO Grey Market Premium (GMP) is reported at +₹20 per share. Based on the upper price band of ₹96, the estimated listing price is ₹116 (+20.8% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Influx Healthtech IPO?

The minimum bid lot size for Influx Healthtech IPO is 1,200 shares. At the cut-off price of ₹96 per share, retail investors need a minimum application amount of ₹1,15,200 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Influx Healthtech IPO allotment status be announced?

The allotment status for Influx Healthtech IPO is scheduled to be finalized on 23 Jun 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Maashitla Securities Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Influx Healthtech IPO allotment status online by PAN?

To check Influx Healthtech IPO allotment status: 1) Visit the registrar portal (Maashitla Securities Private Limited) or the BSE IPO allotment page. 2) Select 'Influx Healthtech Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Influx Healthtech IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums